银屑病
CX3CR1型
趋化因子
免疫系统
单核细胞
体内
免疫学
透明质酸
炎症
精密医学
免疫抑制
医学
髓样
免疫疗法
癌症研究
从长凳到床边
树突状细胞
免疫调节
白细胞贩卖
全身给药
材料科学
重编程
炎症反应
巨噬细胞
微泡
促炎细胞因子
二苯甲酚
靶向治疗
作者
Qian Chen,Xiaodong Zhou,Tian Sun,Hantao Li,Siqi Mai,Yong Miao,Sirong Chen,Jinhong Qin,Xunru Liang,Xin Li,Pengchao Zhao,Liming Bian
摘要
ABSTRACT Current therapies for inflammatory skin diseases predominantly rely on broad systemic immunosuppression and lack precision toward defined immune‐cell subsets. Here, we identify CX3CR1 + nonclassical monocytes (NCMs) as an inflammatory monocyte subset that contributes to the amplification of psoriasiform inflammation, as supported by integrated analyses of human single‐cell transcriptomics, genetic depletion, and adoptive‐transfer models. To preferentially engage these disease‐associated NCMs, we engineer an artificial cell–microneedle platform, termed CX3@GUV‐DMF, comprising CX3CL1‐functionalized, drug‐loaded giant unilamellar vesicles (GUVs) embedded within a dissolvable hyaluronic acid (HA) microneedle array. Following intradermal insertion, surface‐presented CX3CL1 actively navigates GUVs to pathogenic CX3CR1 + NCMs, facilitating the targeted, sustained release of the loaded drug. In vivo evaluations and transcriptomic profiling demonstrate that this localized immunomodulatory strategy attenuates inflammatory myeloid activation, neutrophil infiltration, and Th17‐associated responses while promoting restoration of epidermal barrier‐associated programs. These findings establish a materials‐enabled strategy for subset‐oriented immune modulation and local inflammatory‐niche remodeling, advancing inflammatory skin therapy beyond nonspecific immunosuppression.
科研通智能强力驱动
Strongly Powered by AbleSci AI